Total Voting Rights
Oxford Biomedica PLC announced that as of June 30, 2026, its issued share capital comprises 121,038,363 ordinary shares, with no shares held in treasury. This results in a total of 121,038,363 voting rights, which shareholders can use as the denominator for calculating notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 01 July 2026: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company's issued share capital as at the close of business on 30 June 2026 consisted of 121,038,363 ordinary shares of 50 pence each ("Ordinary Shares"). There are no Ordinary Shares held in treasury.
Accordingly, the total number of voting rights in OXB at the date of this notice is 121,038,363.
The above figure 121,038,363 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, OXB under the FCA's Disclosure Guidance and Transparency Rules.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.